22157.jpg
China Embedded Finance Business and Investment Opportunities Databook 2024: CAGR of 24.9% Forecast from 2024 to 2029, with Market to Reach $132.46 Billion by 2029 
September 23, 2024 07:05 ET | Research and Markets
Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "China Embedded Finance Business and Investment Opportunities Databook - 75+ KPIs on Embedded Lending, Insurance, Payment, and Wealth Segments - Q2...
Logo-uniQure-MS-Word_Orange.jpg
uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease
September 23, 2024 07:05 ET | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, Sept. 23, 2024 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
KBLB logo.jpg
Kraig Biocraft Laboratories Launches Spider Silk Production at Recently Completed Higher Capacity Facility
September 23, 2024 07:05 ET | Kraig Biocraft Laboratories
Kraig Labs (OTCQB:KBLB) begins first BAM-1 parental strains production at its new production center with capacity to support 25 tons of spider silk
Invivyd logo_
Invivyd Provides Detailed Virology Data and Analysis of SARS-CoV-2 Structural Biology Predicting Anticipated Neutralization Activity for PEMGARDA™ (pemivibart)
September 23, 2024 07:01 ET | Invivyd
Independent evaluation of KP.3.1.1 and LB.1 variants shows in vitro pseudovirus neutralization potency of PEMGARDA in-line with prior variants testedProprietary, ongoing SARS-CoV-2 spike analyses...
outbrain_logo.png
Outbrain announces repurchase of remaining 2.95% Convertible Senior Notes due 2026
September 23, 2024 07:00 ET | Outbrain Inc.
NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Outbrain Inc. (NASDAQ: OB), a leading technology platform that drives business results by engaging people across the Open Internet, announced today that...
Skye-DarkBlue.jpg
Skye Bioscience Comments on Monlunabant Phase 2 Top-line Data and Reiterates Confidence in Nimacimab Clinical Development Plan
September 23, 2024 07:00 ET | Skye Bioscience, Inc.
16-week top-line weight loss data validates mechanism of action targeting peripheral CB1 receptors Skye highlights safety advantages of large-molecule CB1 inhibition compared to small-molecule...
black letters white rectangle.jpg
LVT Releases API To Bring Video Security Intelligence To Any Software Ecosystem
September 23, 2024 07:00 ET | LiveView Technologies
Mobile Video Security company LVT releases open API and calls for security company collaboration. Collaboration is the future.
Picture1.jpg
Kamada Announces Expansion of Plasma Collection Operations in Texas with the Opening of New Site in Houston
September 23, 2024 07:00 ET | Kamada Ltd.
New Plasma Collection Center in Houston Now Open, with Planned Annual Collection Capacity of Approximately 50,000 Liters and an Estimated Annual Revenue Contribution of $8 Million to $10 Million at...
Hammond_Primary_Colour_RGB (1).png
Hammond Power Solutions Signs Definitive Agreement to Acquire Assets of Micron Industries Corporation
September 23, 2024 07:00 ET | Hammond Power Solutions Inc
GUELPH, Ontario, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Hammond Power Solutions Inc. (“HPS”) (TSX: HPS.A), a leading manufacturer of dry-type transformers and power quality solutions, today announced...
Logo 1.JPG
Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines Conference
September 23, 2024 07:00 ET | Passage Bio
PHILADELPHIA, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative...